Nonspecific cross-reacting antigen (NCA) is a well-characterized membrane glycoprotein on granulocytes, macrophages, and lung epithelium. Structural studies at the protein and genomic levels have revealed that NCA is a member of the immunoglobulin supergene family, and hybridization studies showed that the transcript level of NCA is induced by treatment with gamma interferon. These studies, as well as the expression of NCA on granulocytes, suggest a role for NCA in immune response. For a first step in studying this possible role, we have examined the binding of two glycoforms of NCA designated NCA-50 (Mr, 50,000) and (M,, 75,000). Here we report the results from binding assays which demonstrate carbohydrate-mediated binding of Escherichia coli expressing type 1 fimbriae and of isolated type 1 fimbriae to NCA-50. TEX-75 did not bind to the purified fimbriae but bound slightly to the bacterial strain. Inhibition studies showed that the binding to NCA-50 involved interaction of mannose moieties on NCA-50 and lectins on the fimbriae. The binding of NCA-50 to bacterial fimbriae was confirmed by electron microscopy studies, using immunolabeling techniques. In addition, we show that the surface expression of NCA-50 (and presumably of other NCA species) on isolated polymorphonuclear leukocytes is increased following activation with the bacterial peptide formylmethionyl-leucyl-phenylalanine, consistent with a role for NCA in immune response.
Nonspecific cross-reacting antigen (NCA) is a highly glycosylated membrane protein found on granulocytes, macrophages, and lung epithelium and in colonic adenocarcinoma. The first NCA form (50 kDa) (NCA-50) was identified by von Kleist et al. (49) and Mach and Pusztaszeri (31) in 1972 and named for its immunological cross-reactivity with carcinoembryonic antigen (CEA), a well-characterized tumor-associated antigen (43) . Since then, several other NCA forms with apparent molecular masses of 50, 75 (designated TEX-75, for tumor-extracted antigen), 90, 95, and 160 kDa (3, 9, 27, 31, 49) have been identified. Protein and nucleotide sequencing have resolved much of the confusion regarding the structures and relatedness of these antigens (2, 18, 21, 32, 35, 38, 46, 48) . NCA-50 and TEX-75 were found to have identical protein sequences and numbers of glycosylation sites but to be distinct glycoproteins differing significantly in carbohydrate content (21) . These same studies revealed the likelihood that TEX-75 (isolated in this laboratory) (27) is equivalent to the NCA-90 identified by Audette et al. (3) , at least with regard to the protein sequence. NCA-95 was found by others to be a unique antigen and to share >85% sequence homology with NCA-50 and TEX-75 (9) . Tissue distribution studies have revealed that NCA-95 is found on granulocytes only, while NCA-50 and TEX-75 are found on granulocytic and epithelial cells (9) . Although not confirmed, it is generally believed that the 160-kDa form of NCA is biliary glycoprotein, a structurally related (4, 22, 23) , but distinct, glycoprotein. To date, only two genes are known for NCA, one encoding NCA-95 (2) and the other encoding NCA-50 or TEX-75 (32, 46) , indicating that much of the size diversity observed for the NCA family members is due to * Corresponding author. differences in the glycosylation patterns of the respective antigens.
Although much is known concerning the structure and tissue distribution of these antigens, only recently have researchers reported possible biological roles for NCA and CEA. Oikawa et al. (34) proposed that NCA functions as a homotypic adhesion molecule, a function similar to that suggested for CEA (6). Oikawa's conclusions were based on the observation of a slight increase (-10%) in cell-cell aggregation of Chinese hamster ovary cells following transfection of NCA cDNA. The relevance of this finding as it relates to NCA antigens on granulocytes, however, remains to be determined. In other studies designed to examine alternative roles, Leusch and coworkers (30) recently described the bacterial binding properties of CEA and provided evidence that NCA had similar properties.
The role of cell surface glycoproteins in mediating bacterial and viral binding is well recognized (40, 51) . Many bacteria express long proteinaceous appendages, called fimbriae or pili, that contain lectins which enable the microorganism to adhere to surface glycoproteins in a carbohydratespecific manner. Oligosaccharide sequences identified as receptors for fimbriae include Manal-3Man for type 1 fimbriae, NeuAca2-3Gal for S fimbriae, and Galotl-4Gal for P fimbriae (5, 41) . The most common and thoroughly characterized of these structures are mannose-specific type 1 fimbriae that are found in about 70% of Escherichia coli strains (37) . Numerous studies have demonstrated the involvement of type 1 fimbriae in bacterial binding to epithelial and phagocytic cells, and there is a positive correlation between the degree of expression of type 1 fimbriae and the susceptibility to phagocytosis by granulocytes in serum-free medium (33, 42 Fig. 3 . The results demonstrate a dose-dependent and saturable binding. E. coli 38 bound most strongly to isolated NCA-50, bound to a much lesser extent to TEX-75 and ovalbumin, and did not bind to fetuin (Fig. 3A) . In contrast to E. coli 38, the isolated type 1 fimbriae bound specifically to NCA-50 and did not bind to TEX-75, fetuin, or ovalbumin (Fig. 3B) . The interaction between type 1 fimbriae and deglycosylated NCA-50, ribonuclease B, and fibronectin was examined as well, but no binding could be detected (data not shown). Negative controls were performed to rule out nonspecific binding. These controls were prepared by adding biotinylated HB101 or unbiotinylated E. coli 38 to the glycoprotein-coated plates or by eliminating the bacteria or the glycoprotein-coating step. None of these controls showed detectable color development above the background level (0.15 absorbance units).
Inhibition of binding to type 1 fimbriae. In order to determine the specificity of the interaction between the carbohydrate moieties on NCA-50 and the bacterial fimbriae, inhibition studies were performed in the presence of three different a-methyl-D-pyranosides using the solid-phase assay described above. The presence of 1 mM MMan inhibited binding of E. coli 38 to the NCA-50-coated plates by 50%, and nearly complete inhibition was obtained with -20 mM MMan (Fig. 4A ). The other saccharides tested either failed to inhibit binding or slightly inhibited binding at much higher sugar concentrations (Fig. 4A) . Adhesion of E. coli 38 to NCA-50 is at least 2 orders of magnitude more sensitive to MMan than to MGlu. The slight degree of binding of E. coli 38 to TEX-75 observed in the previous assays was not inhibited with any of the three sugars, suggesting that the binding was mediated by fimbriae with different sugar specificities or by other membrane components (data not shown).
In contrast to E. coli 38, the binding of purified type 1 fimbriae to NCA-50 was completely inhibited with 1 mM MMan, and 50% inhibition occurred with 0.08 mM MMan (Fig. 4B) localize the binding of NCA-50 to the fimbriae. The fimbriae showed the characteristic diameter of 7 nm for type 1 fimbriae monomers and some fimbriae aggregates (Fig. SA  and B) . Incubation of E. coli 38 with NCA-50 caused extensive agglutination of the bacterial fimbriae, consistent with the presence of multiple fimbriae binding sites (Fig. SC) . Immunolabeling experiments with anti-NCA-reactive monoclonal antibody T84.1E3 and a secondary, gold-labeled goat anti-mouse antibody demonstrated the localization of NCA-50 on the fimbriae (Fig. 5D ). The gold label is especially concentrated in the agglutinated areas. In contrast, the negative controls (no prior incubation with NCA-50 or with T84.1E3) showed only a slight amount of nonspecific labeling (Fig. 5E) .
Effects of fMLP stimulation on the expression of NCA. Others have shown that stimulation of human phagocytic cells enhances the fimbriae-mediated binding of bacteria, presumably by increasing the membrane expression of glycoprotein receptors (10, 26) , and increases in expression of the receptors for complement (52) . On the basis of the results of these studies, we evaluated the changes in membrane surface levels of NCA on human neutrophils by FACS following stimulation with fMLP. The levels of NCA expression on the cell surface after 10 and 40 min of stimulation are shown in Fig. 6 in comparison to unstimulated neutrophils. The level of expression of NCA increased progressively following stimulation with the maximal point (two-to threefold increase) at 40 min (Fig. 6 ). This increase in surface expression was detected almost immediately following activation, suggesting transportation of presynthesized NCA forms from intracellular granules to the cell surface. At longer times (60 and 80 min), the levels of NCA decreased to values between those observed for stimulations of 10 and 40 min (data not shown). The PMNs were stained with trypan blue and examined under the microscope after stimulation in order to assure that the decrease of surface expression after longer exposures to fMLP was not caused by a higher percentage of dead cells (data not shown).
DISCUSSION
In this study, we demonstrate the specific binding of E. coli expressing type 1 fimbriae to NCA-50, a well-characterized glycoprotein found on epithelial cells and granulocytes. The binding was demonstrated in a solid-phase assay using a clinical isolate of E. coli (designated strain 38) shown to express type 1 fimbriae and with fimbriae isolated from E. coli CSH50, a genetically characterized strain known to produce type 1 fimbriae only (Fig. 3) . Here we show that purified type 1 fimbriae bound specifically to NCA-50 and not to TEX-75, ovalbumin, or fetuin (Fig. 3B) . Likewise, no binding of type 1 fimbriae to ribonuclease B or fibronectin could be detected (data not shown). Electron microscopy studies demonstrated that NCA-50 bound along the lengths of the fimbriae (Fig. 5) . These NCA-50 binding locations are consistent with the locations of the fimbriae mannose-specific lectin (FimH) (1, 29) . In contrast to type 1 fimbriae that bound to NCA-50 only, E. coli 38 also bound to TEX-75 to some extent (Fig. 3) (Fig. 4) 
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since the sugar specificity of type 1 fimbriae is well established (41) .
Although the presence of mannose is necessary for mediating binding to type 1 fimbriae (41), the failure of ovalbumin and ribonuclease B (glycoproteins that contain high-mannose saccharides) to bind (Fig. 3) suggests that mannose alone is not sufficient. These results suggest a specific receptor/ligand-like interaction between type 1 fimbriae and the carbohydrate moieties on NCA-50. The precise structural elements recognized by the type 1 fimbriae lectin have not been elucidated; however, the current model predicts that the lectin recognizes a trisaccharide with the structure of a-D-Man(1-3)-,-D-Man(1-4)-D-GlcNAc and contains a hydrophobic region in close proximity to the saccharide binding site (41) . It is thus possible that the lectin recognizes both a carbohydrate and protein sequence, presumably an oligomannose and a hydrophobic amino acid. Evaluation of the structural requirements for mediating binding to type 1 fimbriae will be examined in other studies.
The studies reported required large sample quantities which could be obtained efficiently only from a colonic carcinoma. NCA-50 from malignant tissue has been shown in numerous studies to be identical to that form found on normal lung epithelium and granulocytes (3, 9, 11, 17) . In addition, our carbohydrate analyses (Table 1 , Fig. 1 ) of tumor NCA-50 revealed the presence of a high percentage of high-mannose oligosaccharides, results consistent with the analyses performed on granulocyte NCA-50 isolated from normal spleens (11) . These data indicate that NCA-50 isolated from malignant cells is identical to the NCA-50 from normal lung epithelium and phagocytic cells, leading to the conclusion that their bacterial binding properties would also be identical. With regard to TEX-75, immunological and molecular mass data suggest that the tumor form of TEX-75 is equivalent to the 75-kDa NCA form isolated from normal lung (17) . In consideration of the fact that only two genes have been found for NCA, it is also likely that TEX-75 (isolated in this laboratory) (27) [47] ), and its expression (2.8-kb message) being induced by gamma interferon (25) . The data presented here demonstrating an increase in cell surface expression of NCA on granulocytes following treatment with fMLP ( Fig. 6 ) is consistent with a role for NCA in immune response to bacterial infections. Such a possibility is supported by the work of others who have demonstrated increased fimbriae-mediated bacterial binding to phagocytic cells following activation, presumably due to enhanced expression of the relevant glycoprotein membrane receptors (10, 26) . A similar activation-dependent regulation of receptors for C3b and C3bi has been reported (52) . While monitoring the increase in NCA expression after stimulation with fMLP (Fig. 6) (44) , chemiluminescence (7, 15, 16) , protein iodination (39), degranulation (45) , and activation of protein kinase C (13). Studies with latex particles coated with isolated type 1 fimbriae demonstrated that the fimbriae per se mediated the activation of the granulocytes (16) . In the presence of serum factors, the expression of type 1 fimbriae was also shown to significantly increase the 02 consumption and H202 production by activated granulocytes (16) . As an initial attempt at identifying the type 1 fimbriae receptors, Rodriguez-Ortega and coworkers (40) have purified four prospective glycoprotein receptors from granulocytes with molecular weights of 45,000, 70,000 to 80,000, 100,000, and 150,000. No protein sequence analysis is available on these glycoproteins, precluding comparisons with the NCA forms. Using similar techniques, Giampapa et al. (14) have isolated a 65-kDa type 1 fimbriae receptor from guinea pig erythrocytes. Limited structural analysis of this receptor also prevents any comparison with the NCA we have isolated from human sources. Our future studies will include examination of possible relationships of these glycoprotein receptors with NCA and the biological significance of bacterial binding to NCA.
